Insider · CIK 0002054585
Chris Cleary
director
Files at OBIO (Orchestra BioMed Holdings, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -676 | $3.71 | $2,508 | 36,901 | Feb 6, 2026 |
| Aug 7, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +15,000 | $0.00 | $0 | 37,577 | Aug 8, 2025 |
| Jun 24, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +12,422 | $0.00 | $0 | 22,577 | Jun 26, 2025 |
| Jun 24, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +36,797 | $0.00 | $0 | 36,797 | Jun 26, 2025 |
| Feb 3, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +10,155 | $0.00 | $0 | 10,155 | Feb 5, 2025 |
| Feb 3, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,742 | $0.00 | $0 | 30,742 | Feb 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.